(Q34192914)

31 July 2017

1 reference

title

Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma (English)

1 reference

31 July 2017

0 references

0 references

Thomas PS

1

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Immunology & Cell Biology

31 July 2017

published in

1 reference

31 July 2017

volume

79

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

132-140

1 reference

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Tumour necrosis factor alpha: a potential mediator of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Inflammatory response to acute inhalation of endotoxin in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

TNFalpha mRNA expression in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Expression of inducible nitric oxide in human lung epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Transducing signals of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Inherited variability of tumor necrosis factor production and susceptibility to infectious disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Linkage and candidate gene studies in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Taming TNF: strategies to restrain this proinflammatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.00980.X

10.1046/J.1440-1711.2001.00980.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference